CARY–Inveresk research (Nasdaq:IRGI), a drug development service company, will replace its clinical trial management systems with Siebel Clinical’s product.

Siebel (Nasdaq:IRGI) said its trial management system is the only one that if fully integrated with sales force automation, sales and marketing analytics, and marketing campaign management.

Inveresk will use Siebel Clinical to track study site trip reports; clinical trial status, activity, and calendar management; management reports; and regulatory information. By automating several clinical trial processes and compressing clinical trial timelines, Siebel Clinical will simplify patient recruitment while enhancing trial performance and investigator and customer satisfaction, the company says.

Inveresk, headquarted in Cary, has more than 1,000 employees in 20 countries.